Award

National Institute of Allergy and Infectious Diseases 5R44AI155254-06

Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies

Recipient

DNASTAR, INC.

Award Amount

$1,030,000.00

Ceiling

$1,030,000.00

Awarded

May 01, 2025

Identifier

5R44AI155254-06

Development of a software pipeline for antibody drug discovery to reduce costs and accelerate development by integrating protein structure prediction, docking, and engineering tools.

Description

This project aims to develop a software pipeline to replace costly, time-consuming experimental work in antibody drug discovery with an integrated protein structure prediction, docking, and engineering tools. The goal is to accelerate antibody development and reduce discovery costs by 80-90%, revolutionizing biotech and pharmaceutical research.

View original record